Dexamethasone prevents the induction of COX-2 mRNA and prostaglandins in the lumbar spinal cord following intraplantar FCA in parallel with inhibition of oedema

Neuropharmacology

Volumn 37, Issue 6, 1998, Pages 739-744

  Hay, C H ^a   De Belleroche, J S ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Cyclo oxygenase 2; Dexamethasone; Inflammation; MRNA; Oedema; Prostaglandins; Spinal cord

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ANTIINFLAMMATORY AGENT; BETA TUBULIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DEXAMETHASONE; DRUG VEHICLE; FREUND ADJUVANT; GLUCOCORTICOID; MESSENGER RNA; PROSTAGLANDIN; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; LUMBAR SPINAL CORD; MALE; NONHUMAN; PAIN THRESHOLD; PAW EDEMA; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CYCLOOXYGENASE 2; DEXAMETHASONE; EDEMA; FREUND'S ADJUVANT; GLUCOCORTICOIDS; INJECTIONS, SPINAL; ISOENZYMES; MALE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; RATS; RNA, MESSENGER; SPINAL CORD; SPINAL CORD DISEASES;

EID: 0031863764     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00073-2     Document Type: Article

References (23)

1. Adams J., Collaço-Moraes Y., de Belleroche J. Cyclooxygenase-2 induction in the cerebral cortex: an intracellular response to synaptic excitation. J. Neurochem. 66:1996;6-13.
2. Beiche F., Scheuerer S., Brune K., Geisslinger G., Goppelt-Struebe M. Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett. 390:1996;165-169.
3. Chomczynski P., Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction. Anal. Biochem. 162:1987;156-159.
4. de Belleroche J., Bandopadhyay R., King A. et al. Regional distribution of cholecystokinin messenger RNA in rat brain during development: quantitation and correlation with cholecystokinin immunoreactivity. Neuropeptides. 15:1990;201-212.
5. Dinchuk J.E., Car B.D., Focht R.J. et al. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase 2. Nature. 378:1995;406-409.
6. Draisci G., Iadarola M.J. Temporal analysis of increases in c-fos, preprodynorphin and preproenkephalin mRNAs in rat spinal cord. Mol. Brain Res. 6:1989;31-37.
7. Feinberg A.P., Vogelstein B. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:1983;6-13.
8. Feinberg A.P., Vogelstein B. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity: addendum. Anal. Biochem. 137:1984;266-267.
9. Flower R.J., Rothwell N.J. Lipocortin-1: Cellular mechanisms and clinical relevance. Trends Pharmacol. Sci. 15:1994;71-76.
10. Hall J.L., Dudley L., Dobner P.R., Lewis S.A., Cowan N.J. Identification of two β-tubulin isotopes. Mol. Cell. Biol. 3:1983;854-862.
11. Hay C.H., de Belleroche J. Carrageenan-induced hyperalgesia is associated with increased cyclo-oxygenase-2 expression in spinal cord. NeuroReport. 8:1997;1249-1251.
12. Hay C.H., Trevethick M.A., Wheeldon A., Bowers J.S., de Belleroche J. The potential role of spinal cord cyclooxygenase-2 in the development of Freund's complete adjuvant-induced changes in hyperalgesia and allodynia. Neuroscience. 78:1997;843-850.
13. Iadarola M.J., Brady L.S., Draisci G., Dubner R. Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: stimulus specificity, behavioural parameters and opioid receptor binding. Pain. 35:1988;313-326.
14. Iadarola M.J., Douglass J., Civelli O., Naranjo J.R. Differential activation of spinal cord dynorphin and enkephalin neurons during hyperalgesia: evidence using cDNA hybridisation. Brain Res. 455:1988;205-212.
15. Lee S.H., Soyoola E., Chanmugam P. et al. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J. Biol. Chem. 267:1992;25934-25938.
16. Lowry O.H., Rosebrough N.J., Farr A.L., Randall P.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
17. Masferrer J.L., Zweifel B.S., Manning P.T. et al. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. USA. 91:1994;3228-3232.
18. Murata T., Ushikubi F., Matsuoka T. et al. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature. 388:1997;678-682.
19. Noguchi K., Ruda M.A. Gene regulation in an ascending nociceptive pathway: inflammation-induced increase in preprotachykinin mRNA in rat lamina I spinal projection neurons. J. Neurosci. 12:1992;2563-2572.
20. Portanova J.P., Zhang Y., Anderson G.D. et al. Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia and interleukin 6 production in vivo. J. Exp. Med. 184:1996;883-891.
21. Seibert K., Zhang Y., Leahy K. et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. USA. 91:1994;12013-12017.
22. Stein C., Millan M.J., Herz A. Unilateral inflammation of the hindpaw in rats as a model of prolonged noxious stimulation: alterations in behaviour and nociceptive thresholds. Pharmacol. Biochem. Beh. 31:1988;445-451.
23. Yamagata K., Andreasson K.I., Kaufmann W.E., Barnes C.A., Worley P.F. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron. 11:1993;371-386.